결핵 진료지침

### 참고문헌

1.  Pai M, Denkingger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3-20.
2.  Campbell JR, Pease C, Daley P, Pai M, Menzies D. Chapter 4: Diagnosis of tuberculosis infection. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2022;6(sup1):49-65.
3.  WHO Guidelines Approved by the Guidelines Review Committee. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis - Tests for tuberculosis infection. Geneva: World Health Organization © World Health Organization 2022.; 2022.
4.  CDC. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers June, 2020 [Available from: https://www.cdc.gov/tb/publications/ltbi/default.htm.
5.  Rosales-Klintz S, Bruchfeld J, Haas W, Heldall E, Houben R, van Kessel F, et al. Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area. Eur Respir J. 2019;53(1).
6.  Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192-204.
7.  Mancuso JD, Mody RM, Olsen CH, Harrison LH, Santosham M, Aronson NE. The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study. Chest. 2017;152(2):282-94.
8.  Lee SW, Oh SY, Lee JB, Choi CM, Kim HJ. Tuberculin skin test distribution following a change in BCG vaccination policy. PLoS One. 2014;9(1):e86419.
9.  van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009;180(1):49-58.
10. Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, et

VIII. 잠복결핵감염 <PAGE>331